Seeking Alpha

Pharmasset (VRUS -10.7%) shares plunge after Abbott Laboratories (ABT -0.6%) says interim...

Pharmasset (VRUS -10.7%) shares plunge after Abbott Laboratories (ABT -0.6%) says interim results from a study of its rival experimental hepatitis C drug showed high cure rates. During an analyst meeting, Abbott says the results found that patients with the liver infection can be cured without adding interferon to treatment.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|